Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-01

FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved the original application for a generic fixed-dose combination of olmesartan medoxomil and hydrochlorothiazide. This enables NorthStar RxLLC to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olmesartan Medoxomil and Hydrochlorothiazide (olmesartan medoxomil; hydrochlorothiazide)

Snippet

ORIG AP for OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE)